Skip to main content

Table 2 Univariate and multivariate analysis of baseline characteristics with HCC development

From: Comparison of anti-HBV regimen with or without adefovir on hepatocellular carcinoma development of Chronic hepatitis B patients with compensated cirrhosis: a retrospective cohort study

  univariant analysis p-value multivariant analysis p-value
  HR (95% CI)   HR (95% CI)  
Age 1.00 (0.99–1.01) NS   
Gender:male/female 3.11 (0.99-9.72) NS   
Child-Pugh score: A/B 0.48 (0.21-1.10) NS   
ADV-containing/Non-ADV-treatment 0.18 (0.09-0.43) <0.05 0.18 (0.07-0.45) <0.05
Total bilirubin: < 24/≥ 24 (μmol/L) 0.52 (0.19-1.41) NS   
HBV DNA: <4/≥4 (log copies/ mL) 0.85 (0.41-1.76) NS   
HBeAg: Positive/negative 1.16 (0.54-2.50) NS   
  1. HBeAg hepatitis B e antigen